153 related articles for article (PubMed ID: 37139557)
1. Repurposing the inhibitors of MMP-9 and SGLT-2 against ubiquitin specific protease 30 in Parkinson's disease: computational modelling studies.
Alshehri MM; Danazumi AU; Alshammari MK; Bello RO; Alghazwni MK; Alshehri AM; Alshlali OM; Umar HI
J Biomol Struct Dyn; 2024; 42(3):1307-1318. PubMed ID: 37139557
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.
Bingol B; Tea JS; Phu L; Reichelt M; Bakalarski CE; Song Q; Foreman O; Kirkpatrick DS; Sheng M
Nature; 2014 Jun; 510(7505):370-5. PubMed ID: 24896179
[TBL] [Abstract][Full Text] [Related]
3. Mechanism and regulation of the Lys6-selective deubiquitinase USP30.
Gersch M; Gladkova C; Schubert AF; Michel MA; Maslen S; Komander D
Nat Struct Mol Biol; 2017 Nov; 24(11):920-930. PubMed ID: 28945249
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond.
Bingol B; Sheng M
Free Radic Biol Med; 2016 Nov; 100():210-222. PubMed ID: 27094585
[TBL] [Abstract][Full Text] [Related]
5. Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease.
Park GH; Park JH; Chung KC
BMB Rep; 2021 Dec; 54(12):592-600. PubMed ID: 34674795
[TBL] [Abstract][Full Text] [Related]
6. USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria.
Cunningham CN; Baughman JM; Phu L; Tea JS; Yu C; Coons M; Kirkpatrick DS; Bingol B; Corn JE
Nat Cell Biol; 2015 Feb; 17(2):160-9. PubMed ID: 25621951
[TBL] [Abstract][Full Text] [Related]
7. High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy.
Tufi R; Clark EH; Hoshikawa T; Tsagkaraki C; Stanley J; Takeda K; Staddon JM; Briston T
SLAS Discov; 2023 Apr; 28(3):73-87. PubMed ID: 36608804
[TBL] [Abstract][Full Text] [Related]
8. Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches.
Tsefou E; Walker AS; Clark EH; Hicks AR; Luft C; Takeda K; Watanabe T; Ramazio B; Staddon JM; Briston T; Ketteler R
Biochem J; 2021 Dec; 478(23):4099-4118. PubMed ID: 34704599
[TBL] [Abstract][Full Text] [Related]
9. Beyond Deubiquitylation: USP30-Mediated Regulation of Mitochondrial Homeostasis.
Hou J; Eldeeb M; Wang X
Adv Exp Med Biol; 2017; 1038():133-148. PubMed ID: 29178074
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson's disease.
Miller S; Muqit MMK
Neurosci Lett; 2019 Jul; 705():7-13. PubMed ID: 30995519
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of USP30 activates tissue-specific mitophagy.
Luo H; Krigman J; Zhang R; Yang M; Sun N
Acta Physiol (Oxf); 2021 Jul; 232(3):e13666. PubMed ID: 33890401
[TBL] [Abstract][Full Text] [Related]
12. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model.
Fang TZ; Sun Y; Pearce AC; Eleuteri S; Kemp M; Luckhurst CA; Williams R; Mills R; Almond S; Burzynski L; Márkus NM; Lelliott CJ; Karp NA; Adams DJ; Jackson SP; Zhao JF; Ganley IG; Thompson PW; Balmus G; Simon DK
Nat Commun; 2023 Nov; 14(1):7295. PubMed ID: 37957154
[TBL] [Abstract][Full Text] [Related]
13. USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation.
Rusilowicz-Jones EV; Jardine J; Kallinos A; Pinto-Fernandez A; Guenther F; Giurrandino M; Barone FG; McCarron K; Burke CJ; Murad A; Martinez A; Marcassa E; Gersch M; Buckmelter AJ; Kayser-Bricker KJ; Lamoliatte F; Gajbhiye A; Davis S; Scott HC; Murphy E; England K; Mortiboys H; Komander D; Trost M; Kessler BM; Ioannidis S; Ahlijanian MK; Urbé S; Clague MJ
Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32636217
[TBL] [Abstract][Full Text] [Related]
14. Dual role of USP30 in controlling basal pexophagy and mitophagy.
Marcassa E; Kallinos A; Jardine J; Rusilowicz-Jones EV; Martinez A; Kuehl S; Islinger M; Clague MJ; Urbé S
EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29895712
[TBL] [Abstract][Full Text] [Related]
15. Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling.
Ordureau A; Paulo JA; Zhang J; An H; Swatek KN; Cannon JR; Wan Q; Komander D; Harper JW
Mol Cell; 2020 Mar; 77(5):1124-1142.e10. PubMed ID: 32142685
[TBL] [Abstract][Full Text] [Related]
16. USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death.
Liang JR; Martinez A; Lane JD; Mayor U; Clague MJ; Urbé S
EMBO Rep; 2015 May; 16(5):618-27. PubMed ID: 25739811
[TBL] [Abstract][Full Text] [Related]
17. Novel Imidazole Phenoxyacetic Acids as Inhibitors of USP30 for Neuroprotection Implication via the Ubiquitin-Rho-110 Fluorometric Assay: Design, Synthesis, and In Silico and Biochemical Assays.
Mandal S; Kumar Br P; Alam MT; Tripathi PP; Channappa B
ACS Chem Neurosci; 2022 May; 13(9):1433-1445. PubMed ID: 35417128
[TBL] [Abstract][Full Text] [Related]
18. Atypical Ubiquitination and Parkinson's Disease.
Buneeva O; Medvedev A
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409068
[TBL] [Abstract][Full Text] [Related]
19. Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy.
Kluge AF; Lagu BR; Maiti P; Jaleel M; Webb M; Malhotra J; Mallat A; Srinivas PA; Thompson JE
Bioorg Med Chem Lett; 2018 Aug; 28(15):2655-2659. PubMed ID: 29935771
[TBL] [Abstract][Full Text] [Related]
20. Identification of an autoinhibitory, mitophagy-inducing peptide derived from the transmembrane domain of USP30.
Qin X; Wang R; Xu H; Tu L; Chen H; Li H; Liu N; Wang J; Li S; Yin F; Xu N; Li Z
Autophagy; 2022 Sep; 18(9):2178-2197. PubMed ID: 34989313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
